3Pablo A,Rosenbaum CM,Elizari M,et al.High prevalence of antibodies against betal-and beta2-adrenoceptors in patients with primary electrical cardiac abnormalities[J].J Am Coll Cardiol,1995;26:864-9.
4Poole-wilson PA,Swedberg K,Clclebd JG,et al.Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial(COMET):randomised controlled tria(lJ).Lancet,2003;362:7-13.
7Groote P,Delour P,Mouquet F,et al. The effects of betablockers in patients with stable chronic heart failure. Predictors of left ventrieular ejection fraction improvement and impact on prognosis[J]. Am Heart J,2007,154(3):589.
8Doughty RN,White HD. Carvedilol: use in chronic heart faiture[J]. Expert Rev Cardiovasc Ther, 2007,5 ( 1 ) : 21.
9Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease[J]. Adv Clin Chem, 2005,40 (1):1.
10Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study[J]. J Am Coll Cardiol,2001,37(2) :386.